Breaking News
Get 50% Off 0
Nederlandse versie beschikbaar
Wilt u liever naar Investing.com's Nederlandse editie?
🧠 Smart money is quietly buying these undervalued gems
See Undervalued Stocks
Close

Apellis Pharmaceuticals Inc (APLS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Apellis Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.85 -0.01    -0.02%
15:59:59 - Closed. Currency in USD
After Hours
40.76
-0.08
-0.20%
21:14:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,496,823
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 40.83 - 40.88
Apellis Pharma 40.85 -0.01 -0.02%

APLS User Rankings

 
Users ranking according to the performance of their sentiments for the Apellis Pharmaceuticals Inc stock.
RankUsernameTotalClosedWinningWin %Chg. %
1Chris Klaver44375+40.23%
2Михаил Ефимов111100+31.44%
3Marino Ghilardi111100+6.07%
4BottomCatcher111100+3.31%
5태범 김111100+2.92%
6Alex Nobili111100+2.33%
7Виталий Викторович221500%
8Eduardo Amondo1100-100%
9chanryan991100-100%
10용명 차1100-100%
11Ross Keiser1100-100%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

APLS Comments

Write your thoughts about Apellis Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bryant Warner
Bryant Warner Mar 31, 2026 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
though the ruff
Ahmed Kareem
Ahmed Kareem Jul 28, 2025 8:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The FDA has approved Apellis' EMPAVELI (pegcetacoplan) as the first treatment for *C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN)* in patients aged 12 and older. This approval was announced on *July 28, 2025*. *Key Highlights of the Approval:* - *Efficacy*: EMPAVELI showed a *68% reduction in proteinuria*, stabilized kidney function, and substantial clearance of C3 deposits. - *Label*: Covers adults and adolescents with C3G or primary IC-MPGN, including post-transplant C3G disease recurrence. - *Safety*: A well-established safety profile across over *2,200 patient years* in approved indications. - *Conference Call*: Scheduled for tomorrow at 8:00 a.m. ET to discuss the approval. C3G and primary IC-MPGN are rare kidney diseases with a high risk of progressing to kidney failure. EMPAVELI is now a treatment option for these conditions
Lucian Vlad
Lucian Vlad Nov 01, 2023 12:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Day's Range: 45.75 - 51.00 and maybe more green candles arrive
Lucian Vlad
Lucian Vlad Aug 21, 2023 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in max 3 month APLS will be above 50USD, pls see the main big investors list  , and take actions in consequences :)
Ali Nikpay
Ali Nikpay Aug 11, 2023 3:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Selling 1/3 of position
Antoine Neaime
Antoine Neaime Aug 03, 2023 4:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
big potential here, easy 50% can be made
Hasan YELOK
Hasan YELOK Aug 03, 2023 4:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah, but it just keeps going down every day.
Ali Nikpay
Ali Nikpay Aug 01, 2023 1:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying it
Coşkun YILDIZ
Coşkun YILDIZ Aug 01, 2023 5:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
7 people has some retina damaged probably this news impact the stock. Check news
Giuseppe Di Natale
Giuseppe Di Natale Aug 01, 2023 5:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
7 on over 60.000…
Coşkun YILDIZ
Coşkun YILDIZ Aug 01, 2023 5:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
60000 people or pieces of shrinkage pieces..
Ionut Daniel Zidaru
Ionut Daniel Zidaru Jul 31, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is wrong with this stock?? The earnings are great, the news are great, but it deep 14%
Hasan YELOK
Hasan YELOK Jul 31, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tell me about it...
Daniil Mosiyenko
Daniil Mosiyenko Jul 31, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Maybe manipulation from market-makers
Antoine Neaime
Antoine Neaime Jul 31, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will go up today maybe to 30
Ali Nikpay
Ali Nikpay Jul 25, 2023 12:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy it, short squeeze in few days
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email